Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CG Oncology, Inc. (CGON)
NASDAQ:CGON
Holding CGON?
Track your performance easily
CGON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.77 - $50.23
Previous Close$35.91
Volume344.81K
Average Volume (3M)649.15K
Market Cap
$2.41B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Aug 08, 2024EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume649,149
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$65.50Price Target Upside78.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
CG Oncology, Inc. News
Bulls Say, Bears Say
Bulls Say
Analyst ConfidenceAnalyst maintains a Buy rating for CG Oncology with a price objective of 65.00 USD, indicating confidence in the company's potential.
Market OpportunityCretostimogene is projected to achieve peak sales of over $2.1 billion.
Safety And EfficacyCretostimogene's safety profile is superior with 0% Grade 3+ TRAEs and 0% discontinuation rate compared to TAR-200.
Bears Say
Clinical TrialsThe SunRISe-2 study was discontinued due to TAR-200 failing to show superiority to the chemoradiation comparator arm.
Data InterpretationConfusion on the interpretation of the K-M estimates is likely to persist until final results are seen.
Market CompetitionThe commercial bar is high for CG Oncology given the competition is BCG, indicating challenges in gaining market share.
---
Ownership Overview
30.30% Insiders
8.07% Mutual Funds
0.04% Other Institutional Investors
49.56% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CGON FAQ
What was CG Oncology, Inc.’s price range in the past 12 months?
CG Oncology, Inc. lowest stock price was $25.77 and its highest was $50.23 in the past 12 months.
What is CG Oncology, Inc.’s market cap?
Currently, no data Available
When is CG Oncology, Inc.’s upcoming earnings report date?
CG Oncology, Inc.’s upcoming earnings report date is Aug 08, 2024 which is 89 days ago.
How were CG Oncology, Inc.’s earnings last quarter?
CG Oncology, Inc. released its earnings results on May 09, 2024. The company reported -$0.36 earnings per share for the quarter, missing the consensus estimate of -$0.312 by -$0.048.
Is CG Oncology, Inc. overvalued?
According to Wall Street analysts CG Oncology, Inc.’s price is currently Undervalued.
Does CG Oncology, Inc. pay dividends?
CG Oncology, Inc. does not currently pay dividends.
What is CG Oncology, Inc.’s EPS estimate?
CG Oncology, Inc.’s EPS estimate is -$0.36.
How many shares outstanding does CG Oncology, Inc. have?
CG Oncology, Inc. has 67,077,020 shares outstanding.
What happened to CG Oncology, Inc.’s price movement after its last earnings report?
CG Oncology, Inc. reported an EPS of -$0.36 in its last earnings report, missing expectations of -$0.312. Following the earnings report the stock price went up 7.019%.
Which hedge fund is a major shareholder of CG Oncology, Inc.?
Among the largest hedge funds holding CG Oncology, Inc.’s share is RA Capital Management. It holds CG Oncology, Inc.’s shares valued at 44M.
---
CG Oncology, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$65.50 (78.09% Upside)
$65.50 (78.09% Upside)
Blogger Sentiment
Neutral
CGON Sentiment 50%
Sector Average 74%
Sector Average 74%
Hedge Fund Trend
Increased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $23.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.6%
Last 30 Days ▲ 10.6%
Last 30 Days ▲ 10.6%
CGON Stock 12 Month Forecast
Average Price Target
$65.50
▲(78.09% Upside)
Technical Analysis
Best Analysts Covering CGON
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
-1.42%
reiterated a buy rating 28 days ago
Copying Sam Slutsky's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.42% per trade.
---